Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 May;35(5):424-427.
doi: 10.13201/j.issn.2096-7993.2021.05.009.

[Observation on the efficacy of Eustachian tube dilation hormone under the guidance of endoscope in the treatment of sudden deafness]

[Article in Chinese]
Xiangli Han  1 , Bing Wang  1 , Chen Li  2 , Xin Wang  1 , Han Zhang  2 , Qimei Yang  1 , Wen Zhang  1
Affiliations
Randomized Controlled Trial

[Observation on the efficacy of Eustachian tube dilation hormone under the guidance of endoscope in the treatment of sudden deafness]

[Article in Chinese]
Xiangli Han et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 May.

Abstract
in English, Chinese

Objective:To evaluate the efficacy of Eustachian tube dilation hormone under the guidance of otoscope in the treatment of patients with sudden deafness. Methods:One hundred and seventy-six patients（185 ears） with sudden deafness treated by otorhinolaryngology head and neck surgery in Shaanxi Provincial People's Hospital from January 2020 to December 2020 were selected. According to the inclusion and exclusion criteria, 176 patients（185 ears） were randomly divided into control group（n=86, 90 ears） and study group（n=90, 95 ears）. The control group was treated with intratympanic injection of methylprednisolone（methylprednisolone sodium succinate for injection）, and the study group was treated with tympanic tympanoplasty under otoendoscope. The pure tone hearing threshold, effective rate and the incidence of adverse reactions were compared between the two groups before and after treatment. Results:The total effective rate of the study group was 84.21%（80/95）, slightly lower than that of the control group（84.44%）, but there was no significant difference between the two groups. The hearing threshold of pure tone in the two groups was significantly higher than that before treatment, and the average improvement of hearing in the study group（25.47±6.29） dB was slightly lower than that in the control group（27.33±7.55） dB, but there was no significant difference between the two groups（P>0.05）. There was no significant difference in the incidence of mild adverse reactions between the two groups（P>0.05）. There were no serious adverse reactions. Conclusion:The total effective rate, hearing improvement level and adverse reaction rate of patients with sudden deafness treated with Eustachian tube tympanic dilatation hormone under endoscope are the same as that of tympanic hormone injection.

目的：评估耳内镜引导下导管法咽鼓管吹张激素治疗突发性聋患者的疗效。 方法：选取2020年1月—2020年12月就诊于陕西省人民医院耳鼻咽喉头颈外科的突发性聋高频下降型患者，根据纳入及排除标准纳入176例患者（185耳）作为研究对象，以随机数字表法分成对照组86例（90耳）和研究组90例（95耳）。对照组予以鼓室注射甲泼尼龙（即注射用甲泼尼龙琥珀酸钠）治疗，研究组用耳内镜下咽鼓管鼓室吹张甲泼尼龙治疗，比较两组患者治疗前后纯音听阈值、有效率及用药期间不良反应发生率。 结果：研究组治疗总有效率为84.21%（80/95），略低于对照组的有效率84.44%（76/90），但两组比较差异无统计学意义（P>0.05）。两组纯音听阈值较治疗前明显提高，研究组听力平均提高（25.47±6.29） dB，略低于对照组（27.33±7.55） dB，两组比较差异无统计学意义（P>0.05）；两组治疗方式出现轻微不良反应的发生率比较，差异无统计学意义（P>0.05）。均未出现严重不良反应。 结论：耳内镜下咽鼓管鼓室吹张激素治疗突发性聋患者在治疗总有效率、听力提高水平、不良反应率等方面与鼓室注射激素治疗效果相同。.

Keywords: Eustachian tube dilatation by catheter; endoscope; hormones; sudden deafness.

PubMed Disclaimer

Conflict of interest statement

The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.

References

    1. 中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会 突发性聋诊断和治疗指南(2015) 中华耳鼻咽喉头颈外科杂志. 2015;50(6):443–447. doi: 10.3760/cma.j.issn.1673-0860.2015.06.002. - DOI - PubMed
    1. Gul F, Muderris T, Yalciner G, et al. A comprehensive study of oxidative stress in sudden hearing loss. Eur Arch Otorhinolaryngol. 2017;274(3):1301–1308. doi: 10.1007/s00405-016-4301-1. - DOI - PubMed
    1. Jung SY, Shim HS, Hah YM, et al. Association of Metabolic Syndrome With Sudden Sensorineural Hearing Loss. JAMA Otolaryngol Head Neck Surg. 2018;144(4):308–314. doi: 10.1001/jamaoto.2017.3144. - DOI - PMC - PubMed
    1. Watanabe H, Sano H, Maki A, et al. Investigation of Stress Levels before the Onset of Idiopathic Sudden Sensorineural Hearing Loss. J Int Adv Otol. 2019;15(1):51–55. doi: 10.5152/iao.2019.6197. - DOI - PMC - PubMed
    1. 包 小敏, 李 谦, 余 维, et al. 情绪障碍对突发性聋发病的影响. 国际耳鼻咽喉头颈外科杂志. 2020;44(4):237–240. doi: 10.3760/cma.j.issn.1673-4106.2020.04.012. - DOI

Publication types

Substances

LinkOut - more resources